What's breaking now, across thousands of outlets.
A combination cancer therapy that relies on the reactivation of a tumor suppressor protein to kill leukemic and other blood cancer cells has shown promise in a small pilot trial.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
Less than half of people in Canada know they’re eligible for a flu shot, while only one in four plan to get vaccinated this year Mississauga, ON, Oct.
New research led by experts at the University of Nottingham has revealed how collagen in the tumor environment can alter bowel cancer cell behavior and influence inflammatory responses to…
Kwara State has recorded an increase in childhood vaccination coverage and a decline in malnutrition among children under five, a new health survey reveals Read More…
The hospital operator has lost about $950 million in pretax earnings this year as more patients leave the exchanges. Uncompensated care and delays in elective surgeries from the trend are hitting…
Mumbai: A total of 29,040 students have secured admission to first-year B Pharmacy and Pharm D courses in Maharashtra through the four rounds of the Centralised Admission Process (CAP) for the…
Former Global Fund executive director Mark Dybul returns to the helm in Geneva, facing an unprecedented $5.36 billion funding gap, fraught domestic transitions, and mounting demands to overhaul the…
